Non-profit pharma company Civica, established by hospitals, makes quality generic medications and biosimilar insulin available and affordable for all. Learn about Civica, CivicaScript, Civica Foundation, governance, leadership, membership and history.
Home | Civica Rx | Non-profit Generic Drug & Pharmaceutical Essential ...
Information on Civica manufacturing (Petersburg), medications hospitals use for emergency, surgery, ICU care and serious illness, CivicaScript medicines at the pharmacy counter, and affordable insulin biosimilars for consumers.
Contact Civica directly for inquiries about membership, partnership, drug shortages, adverse events, medical, compliance, media or business development.
Contact | Civica Rx | General inquiries, drug shortages, and adverse ...
Ensuring quality, accessibility and transparency, Civica upholds the highest levels of business ethics and personal integrity in all types of transactions and interactions.
Civica job opportunities and career-building tools in professional and skilled manufacturing roles in Virginia, Utah and remote.
Careers | Civica Rx | Online job postings and information about Civica ...
Images and videos from and about Civica, as well as logos and contacts for media inquiries.
Media Assets | Civica Rx | Images, videos and logos to tell the Civica ...
Civica plans to distribute its insulin glargine to pharmacies across the United States for $45 for a box of five pens, a significant discount in many cases to current prices. Civica recommends that pharmacies and health plans set a maximum recommended price for consumers of no more than $55. This stable, transparent price contrasts with copay assistance programs offered by other manufacturers ...
Civica To Launch Long-Acting Insulin Glargine in the US in January 2026